COVID-19 associated mucormycosis at territory care hospital in South India - A retrospective study
Background: Globally, several cases of mucormycosis have been diagnosed in patients with COVID-19, and the entity is described as COVID-19-associated mucormycosis (CAM). CAM is an emerging problem necessitating increased vigilance in COVID-19 patients, even those who have recovered. The objective wa...
Main Authors: | Sahu S, Patil P, Gafurjiwala SM, Panigrahi M, Kumar Y, Nirupama AY |
---|---|
Format: | Article |
Language: | English |
Published: |
KIMS Foundation and Research Center
2023-04-01
|
Series: | Journal of Medical and Scientific Research |
Subjects: | |
Online Access: | http://jmsronline.com/archive-article/COVID-19-associated-mucormycosis |
Similar Items
-
COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management
by: Farah Yasmin, et al.
Published: (2021-09-01) -
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
by: Laura C. García-Carnero, et al.
Published: (2022-04-01) -
Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India
by: Samir Joshi, et al.
Published: (2022-01-01) -
Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review
by: Naveed Nazir Shah, et al.
Published: (2022-11-01) -
Father–Son COVID‐19‐associated mucormycosis: Important role of genetic susceptibility in combination with environmental factors
by: Mohsen Pourazizi, et al.
Published: (2022-09-01)